Microbot Medical Inc. (MBOT) vs Stereotaxis Inc. (STXS)
Microbot Medical Inc. and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Stereotaxis Inc. is the larger, with a market value of $133.3M against $88.0M — 1.5× the size. Stereotaxis Inc. grew revenue faster over the last twelve months: −5.46% against −59.1%. Stereotaxis Inc. has the higher net margin (−78.5% vs −3,955.2%) and the higher return on invested capital (−203.6% vs −850.5%). Across the 17 metrics below, Stereotaxis Inc. leads on 12 and Microbot Medical Inc. on 5.
Valuation
Profitability
| Metric | MBOT | STXS | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | (166.30%) | 55.57% | 54.62% |
| Operating margin | (4,480.03%) | (75.68%) | 1.64% |
| Net margin | (3,955.22%) | (78.45%) | 0.00% |
| Free cash flow margin | (4,340.11%) | (51.56%) | 1.61% |
| Return on equity | (32.91%) | (344.36%) | 0.00% |
| Return on assets | (30.68%) | (48.76%) | 0.00% |
| Return on invested capital | (850.51%) | (203.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack